National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting, 21200-21201 [2023-07439]
Download as PDF
21200
Federal Register / Vol. 88, No. 68 / Monday, April 10, 2023 / Notices
technology to minimize the information
collection burden.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Maria G. Button,
Director, Executive Secretariat.
National Institutes of Health
[FR Doc. 2023–07410 Filed 4–7–23; 8:45 am]
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Populationbased Research in Vector-borne Disease.
Date: April 17, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 257–
2638, steeleln@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 4, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–07404 Filed 4–7–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:13 Apr 07, 2023
Jkt 259001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIAMS.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for
the review, discussion, and evaluation
of individual intramural programs and
projects conducted by the NATIONAL
INSTITUTE OF ARTHRITIS AND
MUSCULOSKELETAL AND SKIN
DISEASES, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NIAMS.
Date: May 2–3, 2023.
Closed: May 02, 2023, 2:00 p.m. to 4:00
p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 620/630, 35 Convent
Drive, Bethesda, MD 20892.
Closed: May 03, 2023, 10:00 a.m. to 4:00
p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 620/630, 35 Convent
Drive, Bethesda, MD 20892.
Contact Person: John J. O’Shea, MD,
Scientific Director of Intramural Research,
National Institute of Arthritis &
Musculoskeletal and Skin Diseases, Building
10, Bethesda, MD 20892, (301) 496–2612,
osheaj@mail.nih.gov.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Additional Health and Safety Guidance:
Before attending a meeting at an NIH facility,
it is important that visitors review the NIH
COVID–19 Safety Plan at https://
ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
safety-plan/Pages/default.aspx and the NIH
testing and assessment web page at https://
ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/COVID-assessment-testing/Pages/
visitor-testing-requirement.aspx for
information about requirements and
procedures for entering NIH facilities,
especially when COVID–19 community
levels are medium or high. In addition, the
Safer Federal Workforce website has FAQs
for visitors at https://www.saferfederal
workforce.gov/faq/visitors/. Please note that
if an individual has a COVID–19 diagnosis
within 10 days of the meeting, that person
must attend virtually. (For more information
please read NIH’s Requirements for Persons
after Exposure at https://ors.od.nih.gov/sr/
dohs/safety/NIH-covid-19-safety-plan/
COVID-assessment-testing/Pages/personsafter-exposure.aspx and What Happens
When Someone Tests Positive at https://
ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/COVID-assessment-testing/Pages/
test-positive.aspx. Anyone from the public
can attend the open portion of the meeting
virtually via the NIH Videocasting website
(https://videocast.nih.gov). Please continue
checking these websites, in addition to the
committee website listed below, for the most
up to date guidance as the meeting date
approaches.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: April 4, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–07403 Filed 4–7–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Alcohol Abuse and
Alcoholism.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
A portion of this meeting will be
closed to the public in accordance with
E:\FR\FM\10APN1.SGM
10APN1
Federal Register / Vol. 88, No. 68 / Monday, April 10, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism.
Date: May 9, 2023.
Closed: 10:00 a.m. to 10:45 a.m.
Agenda: To review and evaluate grant
applications.
Open: 11:00 a.m. to 3:30 p.m.
Agenda: Presentations and other business
of the Council.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, Conference Rooms A, B & C,
6700B Rockledge Drive, Bethesda, MD 20817.
Contact Person: Ranga V. Srinivas, Ph.D.,
Acting Executive Secretary, National
Advisory Council, Extramural Project Review
Branch, National Institute on Alcohol Abuse
and Alcoholism, National Institutes of
Health, 6700 B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451–2067,
srinivar@mail.nih.gov.
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism,
National Cancer Advisory Board, and
National Advisory Council on Drug Abuse.
Date: May 10, 2022.
Open: 10:00 a.m. to 3:30 p.m.
Agenda: Presentation of NIAAA, NCI, and
NIDA Director’s Update, Scientific Reports,
and other topics within the scope of the
Collaborative Research on Addiction at NIH
(CRAN).
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, Conference Rooms A, B & C,
6700B Rockledge Drive, Bethesda, MD 20817.
Contact Person: Ranga V. Srinivas, Ph.D.,
Acting Executive Secretary, National
Advisory Council, Extramural Project Review
Branch, National Institute on Alcohol Abuse
and Alcoholism, National Institutes of
Health, 6700 B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451–2067,
srinivar@mail.nih.gov.
Paulette S. Gray, Ph.D., Director, Division
of Extramural Activities, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
dea.nci.nih.gov.
Susan Weiss, Ph.D., Director, Division of
Extramural Research, National Institute on
Drug Abuse, National Institutes of Health,
6001 Executive Boulevard, NSC, Room 5274,
Bethesda, MD 20892, 301–443–6487, sweiss@
nida.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
VerDate Sep<11>2014
20:59 Apr 07, 2023
Jkt 259001
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaaa.nih.gov/AboutNIAAA/
AdvisoryCouncil/Pages/default.aspx,
where an agenda and any additional
information for the meeting will be
posted when available.
Additional Health and Safety
Guidance: Before attending a meeting at
an NIH facility, it is important that
visitors review the NIH COVID–19
Safety Plan at https://ors.od.nih.gov/sr/
dohs/safety/NIH-covid-19-safety-plan/
Pages/default.aspx for information
about requirements and procedures for
entering NIH facilities, especially when
COVID–19 community levels are
medium or high. In addition, the Safer
Federal Workforce website has FAQs for
visitors at https://
www.saferfederalworkforce.gov/faq/
visitors/. Please note that if an
individual has a COVID–19 diagnosis
within 10 days of the meeting, that
person must attend virtually. (For more
information, please read NIH’s
Requirements for Persons after Exposure
at https://ors.od.nih.gov/sr/dohs/safety/
NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/persons-afterexposure.aspx and What Happens When
Someone Tests Positive at https://
ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVIDassessment-testing/Pages/testpositive.aspx.) Anyone from the public
can attend the open portion of the
meeting virtually via the NIH
Videocasting website (https://
videocast.nih.gov). Please continue
checking these websites, in addition to
the committee website listed below, for
the most up to date guidance as the
meeting date approaches.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.273, Alcohol Research
Programs, National Institutes of Health, HHS)
Dated: April 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–07439 Filed 4–7–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
21201
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors Chairs Meeting, Office of the
Director, National Institutes of Health.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
Name of Committee: Board of Scientific
Counselors Chairs Meeting, National
Institutes of Health.
Date: May 12, 2023.
Time: 12:00 p.m. to 3:00 p.m., EST.
Agenda: The meeting will include a
discussion of policies and procedures that
apply to the regular review of NIH intramural
scientists and their work.
Place: National Institutes of Health, 1
Center Drive, Building 1, Room 160,
Bethesda, MD 20892 (Zoom Meeting).
This meeting is a virtual meeting via Zoom
and can be accessed at: https://
nih.zoomgov.com/j/1605138302?pwd=
b0VTMUhtSnBzOE5kcTJuSTR5akpYQT09.
Meeting ID: 160 513 8302.
Passcode: 183436.
One tap mobile
+16692545252,,1605138302#,,,,*183436# US
(San Jose)
+16468287666,,1605138302#,,,,*183436# US
(New York)
Dial by your location:
+1 669 254 5252 US (San Jose)
+1 646 828 7666 US (New York)
+1 551 285 1373 US
+1 669 216 1590 US (San Jose)
Meeting ID: 160 513 8302.
Passcode: 183436.
Find your local number: https://
nih.zoomgov.com/u/acYh8huRe6.
Contact Person: Margaret McBurney,
Management Analyst, Office of the Deputy
Director for Intramural Research, National
Institutes of Health, 1 Center Drive, Room
160, Bethesda, MD 20892–0140, (301) 496–
1921, mmcburney@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the Office
of Intramural Research home page: https://
sourcebook.od.nih.gov/.
Dated: April 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–07464 Filed 4–7–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\10APN1.SGM
10APN1
Agencies
[Federal Register Volume 88, Number 68 (Monday, April 10, 2023)]
[Notices]
[Pages 21200-21201]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07439]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council on Alcohol Abuse and Alcoholism.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
A portion of this meeting will be closed to the public in
accordance with
[[Page 21201]]
the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Alcohol Abuse
and Alcoholism.
Date: May 9, 2023.
Closed: 10:00 a.m. to 10:45 a.m.
Agenda: To review and evaluate grant applications.
Open: 11:00 a.m. to 3:30 p.m.
Agenda: Presentations and other business of the Council.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, Conference Rooms A, B & C, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Ranga V. Srinivas, Ph.D., Acting Executive
Secretary, National Advisory Council, Extramural Project Review
Branch, National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, 6700 B Rockledge Drive, Room 2114, Bethesda,
MD 20892, (301) 451-2067, [email protected].
Name of Committee: National Advisory Council on Alcohol Abuse
and Alcoholism, National Cancer Advisory Board, and National
Advisory Council on Drug Abuse.
Date: May 10, 2022.
Open: 10:00 a.m. to 3:30 p.m.
Agenda: Presentation of NIAAA, NCI, and NIDA Director's Update,
Scientific Reports, and other topics within the scope of the
Collaborative Research on Addiction at NIH (CRAN).
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, Conference Rooms A, B & C, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Ranga V. Srinivas, Ph.D., Acting Executive
Secretary, National Advisory Council, Extramural Project Review
Branch, National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, 6700 B Rockledge Drive, Room 2114, Bethesda,
MD 20892, (301) 451-2067, [email protected].
Paulette S. Gray, Ph.D., Director, Division of Extramural
Activities, National Cancer Institute, National Institutes of
Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892,
240-276-6340, [email protected].
Susan Weiss, Ph.D., Director, Division of Extramural Research,
National Institute on Drug Abuse, National Institutes of Health,
6001 Executive Boulevard, NSC, Room 5274, Bethesda, MD 20892, 301-
443-6487, [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Information is also available on the Institute's/Center's home
page: https://www.niaaa.nih.gov/AboutNIAAA/AdvisoryCouncil/Pages/default.aspx, where an agenda and any additional information for the
meeting will be posted when available.
Additional Health and Safety Guidance: Before attending a meeting
at an NIH facility, it is important that visitors review the NIH COVID-
19 Safety Plan at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx for information about requirements and
procedures for entering NIH facilities, especially when COVID-19
community levels are medium or high. In addition, the Safer Federal
Workforce website has FAQs for visitors at https://www.saferfederalworkforce.gov/faq/visitors/. Please note that if an
individual has a COVID-19 diagnosis within 10 days of the meeting, that
person must attend virtually. (For more information, please read NIH's
Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx and What Happens When Someone Tests
Positive at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx.) Anyone from
the public can attend the open portion of the meeting virtually via the
NIH Videocasting website (https://videocast.nih.gov). Please continue
checking these websites, in addition to the committee website listed
below, for the most up to date guidance as the meeting date approaches.
(Catalogue of Federal Domestic Assistance Program Nos. 93.273,
Alcohol Research Programs, National Institutes of Health, HHS)
Dated: April 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07439 Filed 4-7-23; 8:45 am]
BILLING CODE 4140-01-P